BlackRock Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
BA
BIT
BFA
BlackRock Group's DGX Position: Q4 2016 in Review
BlackRock Group increased its Quest Diagnostics (DGX) stake by 44% in Q4 2016, buying an estimated $52.1M and bringing the position to 1,973,675 shares worth $181M. The position accounts for 0.09% of the portfolio, ranked #272.
BlackRock Group first reported a position in DGX in Q2 2013 and has held it in 15 quarters since. 598 funds tracked by Wall St. Rank hold DGX as of Q4 2016.
- BlackRock Group held 1,973,675 shares of Quest Diagnostics worth $181M as of Q4 2016.
- BlackRock Group bought 603,922 Quest Diagnostics shares in Q4 2016, an estimated $52.1M.
- Quest Diagnostics made up 0.09% of BlackRock Group's portfolio in Q4 2016, its #272 holding.
- BlackRock Group first reported a position in Quest Diagnostics in Q2 2013 and has held it in 15 quarters since.
- 598 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.
Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.